SCHEMBL8287930

SCHEMBL8287930

CCOC(=O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.47
KDM4E B2RXH2 4/20 0.43
HTT P42858 1/20 0.43
GABRP O00591 6/20 0.43
GABRD O14764 6/20 0.43
GABRA1 P14867 6/20 0.43
GABRB1 P18505 6/20 0.43
GABRG2 P18507 6/20 0.43
GABRB3 P28472 6/20 0.43
GABRA5 P31644 6/20 0.43
GABRA3 P34903 6/20 0.43
GABRA2 P47869 6/20 0.43
GABRB2 P47870 6/20 0.43
GABRA4 P48169 6/20 0.43
GABRE P78334 6/20 0.43
GABRA6 Q16445 6/20 0.43
GABRG1 Q8N1C3 6/20 0.43
GABRG3 Q99928 6/20 0.43
GABRQ Q9UN88 6/20 0.43
MAT2A P31153 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287920 0.87 CSF1R (0.37) CSF1RKDM4EHTTMAT2AMAPT
SCHEMBL8285291 0.86 GABRA1 (0.40) CSF1RKDM4EHTTGABRPGABRD
SCHEMBL8286468 0.85 GSK3B (0.38) CSF1RKDM4EHTTMAT2AALDH1A1
SCHEMBL8287593 0.85 GSK3B (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8287205 0.84 GSK3B (0.37) CSF1RPDE4B
SCHEMBL8287486 0.84 LMNA (0.37) CSF1RMAT2AALDH1A1MAPTLMNA
SCHEMBL8287248 0.83 MEN1 (0.43) CSF1RKDM4EHTTMAT2ASPR
SCHEMBL8287565 0.83 HTT (0.41) CSF1RKDM4EHTTMAT2ASPR
SCHEMBL8362924 0.82 GSK3B (0.39) CSF1RMAT2AALDH1A1MAPTGAA
SCHEMBL8286472 0.82 EGFR (0.46) KDM4EMAT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed